Victory Capital Management Inc. Decreases Stake in Bath & Body Works, Inc. $BBWI

Victory Capital Management Inc. lessened its stake in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 34.7% during the 3rd quarter, Holdings Channel reports. The firm owned 8,510,117 shares of the company’s stock after selling 4,526,152 shares during the quarter. Victory Capital Management Inc.’s holdings in Bath & Body Works were worth $219,221,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. First Horizon Corp purchased a new stake in shares of Bath & Body Works during the third quarter valued at $29,000. Geneos Wealth Management Inc. lifted its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Parkside Financial Bank & Trust grew its stake in Bath & Body Works by 24.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after purchasing an additional 364 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new position in shares of Bath & Body Works in the third quarter valued at about $54,000. Finally, Westfuller Advisors LLC purchased a new position in shares of Bath & Body Works in the third quarter worth about $56,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works News Roundup

Here are the key news stories impacting Bath & Body Works this week:

  • Positive Sentiment: PEEPS collaboration and spring merchandising interest could help drive seasonal traffic and basket uplift, a potential short‑term retail tailwind. BBWI Valuation / PEEPS collaboration
  • Neutral Sentiment: Deutsche Bank raised its price target from $21 to $22 but kept a “hold” rating (small change). Deutsche Bank adjusts PT
  • Neutral Sentiment: Barclays lifted its target from $20 to $21 and kept an “equal weight” rating — another modest analyst tweak rather than an upgrade. Barclays raises PT
  • Neutral Sentiment: Bath & Body Works released fourth‑quarter and full‑year 2025 results and issued the 2026 guidance package; details are in the company press release. Q4 and FY2025 results & 2026 guidance
  • Negative Sentiment: FY‑2026 EPS guidance came in at $2.40–$2.65 versus consensus ~$2.74 — a modest miss that signals more constrained full‑year profit expectations.
  • Negative Sentiment: Q1‑2026 EPS guidance was cut sharply to $0.24–$0.30 versus consensus ~$1.17, flagging an earnings shortfall early in the year and driving the immediate negative reaction.
  • Negative Sentiment: Numerous law firms announced or promoted class‑action filings and lead‑plaintiff deadlines related to the company (multiple notices/deadlines through March 13–16), increasing legal overhang and headline risk. Pomerantz investor alert
  • Negative Sentiment: Cooper Creek liquidated ~5.0M shares in Q4 (≈$129M stake decline), a significant institutional sale that can pressure the stock and signal reduced conviction from a prior holder. Cooper Creek liquidation

Analysts Set New Price Targets

A number of brokerages recently commented on BBWI. Barclays upped their target price on Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday. The Goldman Sachs Group downgraded shares of Bath & Body Works from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $39.00 to $17.00 in a report on Thursday, November 20th. Bank of America set a $26.00 price objective on shares of Bath & Body Works in a research note on Monday, November 24th. Citigroup downgraded shares of Bath & Body Works from a “buy” rating to a “neutral” rating and boosted their target price for the company from $21.00 to $25.00 in a research report on Tuesday, February 17th. Finally, Jefferies Financial Group started coverage on Bath & Body Works in a research report on Wednesday, January 14th. They set a “hold” rating and a $24.00 price target on the stock. Three analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $23.86.

View Our Latest Stock Report on Bath & Body Works

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $22.43 on Wednesday. The company’s fifty day moving average price is $22.25 and its 200 day moving average price is $23.59. The stock has a market capitalization of $4.59 billion, a P/E ratio of 6.90, a P/E/G ratio of 0.97 and a beta of 1.48. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $35.21.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.76 by $0.29. Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The business had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.59 billion. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 20th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 20th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.6%. Bath & Body Works’s payout ratio is currently 24.62%.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Further Reading

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.